Qualigen Therapeutics (QLGN) Competitors $3.90 -0.14 (-3.47%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends QLGN vs. SLGL, WENA, AWH, IPA, IMNN, CRVO, RLMD, TLPH, KZIA, and KPRXShould you be buying Qualigen Therapeutics stock or one of its competitors? The main competitors of Qualigen Therapeutics include Sol-Gel Technologies (SLGL), ANEW Medical (WENA), Aspira Women's Health (AWH), ImmunoPrecise Antibodies (IPA), Imunon (IMNN), CervoMed (CRVO), Relmada Therapeutics (RLMD), Talphera (TLPH), Kazia Therapeutics (KZIA), and Kiora Pharmaceuticals (KPRX). These companies are all part of the "pharmaceutical products" industry. Qualigen Therapeutics vs. Sol-Gel Technologies ANEW Medical Aspira Women's Health ImmunoPrecise Antibodies Imunon CervoMed Relmada Therapeutics Talphera Kazia Therapeutics Kiora Pharmaceuticals Qualigen Therapeutics (NASDAQ:QLGN) and Sol-Gel Technologies (NASDAQ:SLGL) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, community ranking, profitability, media sentiment, valuation, analyst recommendations, dividends and institutional ownership. Does the MarketBeat Community favor QLGN or SLGL? Sol-Gel Technologies received 142 more outperform votes than Qualigen Therapeutics when rated by MarketBeat users. However, 87.50% of users gave Qualigen Therapeutics an outperform vote while only 63.40% of users gave Sol-Gel Technologies an outperform vote. CompanyUnderperformOutperformQualigen TherapeuticsOutperform Votes787.50% Underperform Votes112.50%Sol-Gel TechnologiesOutperform Votes14963.40% Underperform Votes8636.60% Which has better earnings & valuation, QLGN or SLGL? Qualigen Therapeutics has higher earnings, but lower revenue than Sol-Gel Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQualigen Therapeutics$4.98M0.58-$13.42MN/AN/ASol-Gel Technologies$11.71M1.02-$27.24M-$0.34-1.26 Is QLGN or SLGL more profitable? Qualigen Therapeutics has a net margin of 0.00% compared to Sol-Gel Technologies' net margin of -81.75%. Qualigen Therapeutics' return on equity of 0.00% beat Sol-Gel Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Qualigen TherapeuticsN/A N/A -424.18% Sol-Gel Technologies -81.75%-27.17%-22.49% Which has more risk and volatility, QLGN or SLGL? Qualigen Therapeutics has a beta of -0.7, suggesting that its stock price is 170% less volatile than the S&P 500. Comparatively, Sol-Gel Technologies has a beta of 1.62, suggesting that its stock price is 62% more volatile than the S&P 500. Do analysts recommend QLGN or SLGL? Sol-Gel Technologies has a consensus price target of $5.00, suggesting a potential upside of 1,065.50%. Given Sol-Gel Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Sol-Gel Technologies is more favorable than Qualigen Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Qualigen Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Sol-Gel Technologies 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals believe in QLGN or SLGL? 3.2% of Qualigen Therapeutics shares are held by institutional investors. Comparatively, 26.2% of Sol-Gel Technologies shares are held by institutional investors. 1.8% of Qualigen Therapeutics shares are held by insiders. Comparatively, 66.5% of Sol-Gel Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the media prefer QLGN or SLGL? In the previous week, Qualigen Therapeutics had 1 more articles in the media than Sol-Gel Technologies. MarketBeat recorded 1 mentions for Qualigen Therapeutics and 0 mentions for Sol-Gel Technologies. Qualigen Therapeutics' average media sentiment score of 0.00 equaled Sol-Gel Technologies'average media sentiment score. Company Overall Sentiment Qualigen Therapeutics Neutral Sol-Gel Technologies Neutral SummarySol-Gel Technologies beats Qualigen Therapeutics on 10 of the 15 factors compared between the two stocks. Ad WealthPressYour chance to get on the next “60-Second Trade”Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday!Just head over here! Get Qualigen Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for QLGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart QLGN vs. The Competition Export to ExcelMetricQualigen TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.87M$6.57B$5.14B$9.08BDividend YieldN/A2.99%5.09%4.23%P/E RatioN/A10.5989.9717.18Price / Sales0.58196.061,116.26117.06Price / CashN/A57.1643.1037.85Price / Book-0.195.094.784.78Net Income-$13.42M$151.83M$120.31M$225.60M7 Day Performance0.78%-2.14%-1.92%-1.23%1 Month Performance-19.25%-4.56%13.65%0.46%1 Year Performance-86.55%8.87%28.34%15.24% Qualigen Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)QLGNQualigen TherapeuticsN/A$3.90-3.5%N/A-86.4%$2.87M$4.98M0.0050News CoverageSLGLSol-Gel Technologies2.4191 of 5 stars$0.45-5.3%$5.00+1,000.6%-66.5%$12.66M$1.55M-1.3650WENAANEW MedicalN/A$0.73-0.5%N/AN/A$12.51MN/A0.00N/AGap UpAWHAspira Women's Health1.2118 of 5 stars$0.74-1.5%$4.40+495.6%-69.7%$12.32M$9.15M-0.62110Analyst ForecastIPAImmunoPrecise Antibodies2.954 of 5 stars$0.42+4.1%$5.00+1,090.5%-69.5%$12.11M$24.07M-0.5280News CoverageIMNNImunon2.3547 of 5 stars$0.84-1.1%$20.50+2,355.1%+9.2%$12.11M$500,000.00-0.4533Analyst ForecastNews CoverageGap UpCRVOCervoMed2.1773 of 5 stars$1.92+1.1%$42.00+2,087.5%-67.1%$11.85M$7.14M0.004Analyst DowngradeAnalyst RevisionHigh Trading VolumeRLMDRelmada Therapeutics4.1944 of 5 stars$0.39+5.3%$4.25+999.6%-87.7%$11.66MN/A-0.1310Gap DownHigh Trading VolumeTLPHTalphera2.8909 of 5 stars$0.67+3.1%$4.50+571.5%N/A$11.41M$281,000.00-0.9419Positive NewsKZIAKazia Therapeutics1.7282 of 5 stars$3.41-3.9%$20.00+486.5%-21.6%$11.35M$2.31M0.0012Gap UpKPRXKiora Pharmaceuticals2.1037 of 5 stars$3.68+10.8%$10.00+171.7%-32.5%$11.04M$16M0.0010Positive NewsGap Up Related Companies and Tools Related Companies SLGL Competitors WENA Competitors AWH Competitors IPA Competitors IMNN Competitors CRVO Competitors RLMD Competitors TLPH Competitors KZIA Competitors KPRX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:QLGN) was last updated on 12/22/2024 by MarketBeat.com Staff From Our Partners⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Qualigen Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Qualigen Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free QLGN Stock Alerts